Chikuma Hamada

6.6k citations
143 papers · 4.6k · 1 hit paper · h-index 30

Impact in

Papers in

    • Statistical Methods in Clinical Trials 36
    • Statistical Methods and Bayesian Inference 6
    • Colorectal Cancer Surgical Treatments 17
    • Colorectal Cancer Treatments and Studies 13

Chikuma Hamada

132 papers receiving 4.4k citations

Chikuma Hamada's Hit Papers

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial 2017 · 771 citations
7710+3+6Years since publication250500750

Peers

Chikuma Hamada
Comparison fields: 5 of 132
  • Neurology 953
  • Clinical Biochemistry 147
  • Oncology 680
  • Pulmonary and Respiratory Medicine 800
  • Statistics and Probability 293
Replace Atul B Mehta with:
Atul B Mehta United Kingdom
Vinay Chaudhry United States
Greta R. Bunin United States
Pramod Kumar Mistry United States
Gregory T. Jones New Zealand
Silverio Perrotta Italy
William R. Bamlet United States
Kelly A. Volcik United States
Yves Benoît Belgium
Gregory M. Pastores United States
Chikuma Hamada relative to Atul B Mehta United Kingdom Atul B Mehta's profile →
Citations per field
00.5×5×11.3×
Atul B Mehta · 1×
Citations per year

Countries citing papers authored by Chikuma Hamada

Since Specialization
Citations

This map shows the geographic impact of Chikuma Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chikuma Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chikuma Hamada more than expected).

Fields of papers citing papers by Chikuma Hamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chikuma Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chikuma Hamada. The network helps show where Chikuma Hamada may publish in the future.

Co-authors

The 25 scholars most cited alongside Chikuma Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chikuma Hamada Line = papers co-authored together Chikuma Hamada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2017771
2 2010404
3 2014298
4 2012273
5 2005215
6 2000162
7 2004140
8 2012129
9 2011120
10 1998117
11 2009107
12 201787
13 199684
14 199982
15 200571
16 199867
17 199966
18 200353
19 199950
20 201443

About Chikuma Hamada

Chikuma Hamada is a scholar working on Statistics and Probability, Oncology, Toxicology, Statistics, Probability and Uncertainty and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 4.6k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (36 papers), Colorectal Cancer Surgical Treatments (17 papers), Colorectal Cancer Treatments and Studies (13 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers), Meta-analysis and systematic reviews (6 papers), Animal testing and alternatives (6 papers), Statistical Methods and Bayesian Inference (6 papers) and Gene expression and cancer classification (5 papers). The work is most often cited by research in Neurology (953 citations), Clinical Biochemistry (147 citations), Oncology (680 citations), Pulmonary and Respiratory Medicine (800 citations) and Statistics and Probability (293 citations). Chikuma Hamada has collaborated with scholars based in Japan and United States. Frequent co-authors include Isao Yoshimura, Hiroyuki Morita, Takao Sugiyama, Hiroki Kurihara, Mitsuo Ohta, Ken Kodama, Shigefumi Fujimura, Munehisa Imaizumi, Yoshio Yazaki and Hiromi Wada. Their work appears in journals such as Journal of Biopharmaceutical Statistics, Pharmaceutical Statistics, International Journal of Clinical Oncology, Statistics in Medicine and Drug Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact